Logo image of IFX.DE

INFINEON TECHNOLOGIES AG (IFX.DE) Stock Fundamental Analysis

FRA:IFX - Deutsche Boerse Ag - DE0006231004 - Common Stock - Currency: EUR

36.025  -0.81 (-2.2%)

Fundamental Rating

4

Taking everything into account, IFX scores 4 out of 10 in our fundamental rating. IFX was compared to 58 industry peers in the Semiconductors & Semiconductor Equipment industry. There are concerns on the financial health of IFX while its profitability can be described as average. IFX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

IFX had positive earnings in the past year.
In the past year IFX had a positive cash flow from operations.
IFX had positive earnings in each of the past 5 years.
IFX had a positive operating cash flow in each of the past 5 years.
IFX.DE Yearly Net Income VS EBIT VS OCF VS FCFIFX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

IFX's Return On Assets of 3.13% is on the low side compared to the rest of the industry. IFX is outperformed by 74.14% of its industry peers.
Looking at the Return On Equity, with a value of 5.11%, IFX is doing worse than 72.41% of the companies in the same industry.
IFX has a worse Return On Invested Capital (5.98%) than 60.34% of its industry peers.
IFX had an Average Return On Invested Capital over the past 3 years of 11.24%. This is below the industry average of 16.14%.
The 3 year average ROIC (11.24%) for IFX is well above the current ROIC(5.98%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 3.13%
ROE 5.11%
ROIC 5.98%
ROA(3y)7.79%
ROA(5y)5.95%
ROE(3y)13.34%
ROE(5y)10.66%
ROIC(3y)11.24%
ROIC(5y)8.52%
IFX.DE Yearly ROA, ROE, ROICIFX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of IFX (6.34%) is worse than 79.31% of its industry peers.
IFX's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 12.38%, IFX is not doing good in the industry: 62.07% of the companies in the same industry are doing better.
IFX's Operating Margin has improved in the last couple of years.
IFX has a worse Gross Margin (39.68%) than 72.41% of its industry peers.
IFX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.38%
PM (TTM) 6.34%
GM 39.68%
OM growth 3Y8.56%
OM growth 5Y3.29%
PM growth 3Y-6.29%
PM growth 5Y-4.73%
GM growth 3Y1.76%
GM growth 5Y1.71%
IFX.DE Yearly Profit, Operating, Gross MarginsIFX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

3

2. Health

2.1 Basic Checks

IFX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
IFX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for IFX has been increased compared to 5 years ago.
IFX has a worse debt/assets ratio than last year.
IFX.DE Yearly Shares OutstandingIFX.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
IFX.DE Yearly Total Debt VS Total AssetsIFX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

An Altman-Z score of 3.69 indicates that IFX is not in any danger for bankruptcy at the moment.
The Altman-Z score of IFX (3.69) is worse than 65.52% of its industry peers.
The Debt to FCF ratio of IFX is 7.98, which is on the high side as it means it would take IFX, 7.98 years of fcf income to pay off all of its debts.
IFX's Debt to FCF ratio of 7.98 is on the low side compared to the rest of the industry. IFX is outperformed by 62.07% of its industry peers.
IFX has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
IFX's Debt to Equity ratio of 0.26 is in line compared to the rest of the industry. IFX outperforms 51.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 7.98
Altman-Z 3.69
ROIC/WACC0.61
WACC9.86%
IFX.DE Yearly LT Debt VS Equity VS FCFIFX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.98 indicates that IFX should not have too much problems paying its short term obligations.
IFX has a Current ratio of 1.98. This is in the lower half of the industry: IFX underperforms 62.07% of its industry peers.
IFX has a Quick Ratio of 1.11. This is a normal value and indicates that IFX is financially healthy and should not expect problems in meeting its short term obligations.
IFX has a worse Quick ratio (1.11) than 63.79% of its industry peers.
Industry RankSector Rank
Current Ratio 1.98
Quick Ratio 1.11
IFX.DE Yearly Current Assets VS Current LiabilitesIFX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

The earnings per share for IFX have decreased strongly by -33.86% in the last year.
Measured over the past years, IFX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.75% on average per year.
Looking at the last year, IFX shows a decrease in Revenue. The Revenue has decreased by -8.61% in the last year.
The Revenue has been growing by 13.25% on average over the past years. This is quite good.
EPS 1Y (TTM)-33.86%
EPS 3Y15.94%
EPS 5Y15.75%
EPS Q2Q%-35.85%
Revenue 1Y (TTM)-8.61%
Revenue growth 3Y10.58%
Revenue growth 5Y13.25%
Sales Q2Q%-7.51%

3.2 Future

The Earnings Per Share is expected to grow by 12.00% on average over the next years. This is quite good.
Based on estimates for the next years, IFX will show a small growth in Revenue. The Revenue will grow by 6.50% on average per year.
EPS Next Y-15.46%
EPS Next 2Y8.45%
EPS Next 3Y12.85%
EPS Next 5Y12%
Revenue Next Year0.85%
Revenue Next 2Y6.15%
Revenue Next 3Y7.49%
Revenue Next 5Y6.5%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IFX.DE Yearly Revenue VS EstimatesIFX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
IFX.DE Yearly EPS VS EstimatesIFX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

IFX is valuated rather expensively with a Price/Earnings ratio of 21.44.
Compared to the rest of the industry, the Price/Earnings ratio of IFX is on the same level as its industry peers.
IFX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 29.35.
A Price/Forward Earnings ratio of 16.38 indicates a correct valuation of IFX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IFX indicates a somewhat cheap valuation: IFX is cheaper than 68.97% of the companies listed in the same industry.
IFX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 21.44
Fwd PE 16.38
IFX.DE Price Earnings VS Forward Price EarningsIFX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

IFX's Enterprise Value to EBITDA is on the same level as the industry average.
IFX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 70.32
EV/EBITDA 13.39
IFX.DE Per share dataIFX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as IFX's earnings are expected to grow with 12.85% in the coming years.
PEG (NY)N/A
PEG (5Y)1.36
EPS Next 2Y8.45%
EPS Next 3Y12.85%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.95%, IFX is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.50, IFX has a dividend in line with its industry peers.
With a Dividend Yield of 0.95, IFX pays less dividend than the S&P500 average, which is at 2.33.
Industry RankSector Rank
Dividend Yield 0.95%

5.2 History

The dividend of IFX is nicely growing with an annual growth rate of 6.41%!
Dividend Growth(5Y)6.41%
Div Incr Years3
Div Non Decr Years3
IFX.DE Yearly Dividends per shareIFX.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

48.98% of the earnings are spent on dividend by IFX. This is a bit on the high side, but may be sustainable.
The dividend of IFX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP48.98%
EPS Next 2Y8.45%
EPS Next 3Y12.85%
IFX.DE Yearly Income VS Free CF VS DividendIFX.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
IFX.DE Dividend Payout.IFX.DE Dividend Payout, showing the Payout Ratio.IFX.DE Dividend Payout.PayoutRetained Earnings

INFINEON TECHNOLOGIES AG

FRA:IFX (3/7/2025, 7:00:00 PM)

36.025

-0.81 (-2.2%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-04 2025-02-04/bmo
Earnings (Next)05-08 2025-05-08/amc
Inst Owners53.97%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap47.05B
Analysts81.29
Price Target42.85 (18.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.95%
Yearly Dividend0.35
Dividend Growth(5Y)6.41%
DP48.98%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.37%
Min EPS beat(2)2.81%
Max EPS beat(2)23.94%
EPS beat(4)4
Avg EPS beat(4)9.72%
Min EPS beat(4)1.58%
Max EPS beat(4)23.94%
EPS beat(8)8
Avg EPS beat(8)9.31%
EPS beat(12)12
Avg EPS beat(12)9.09%
EPS beat(16)14
Avg EPS beat(16)8.5%
Revenue beat(2)1
Avg Revenue beat(2)1.54%
Min Revenue beat(2)-2.46%
Max Revenue beat(2)5.55%
Revenue beat(4)1
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-3.32%
Max Revenue beat(4)5.55%
Revenue beat(8)3
Avg Revenue beat(8)-0.34%
Revenue beat(12)6
Avg Revenue beat(12)0.43%
Revenue beat(16)8
Avg Revenue beat(16)0.38%
PT rev (1m)8.22%
PT rev (3m)10.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.87%
EPS NY rev (1m)6.75%
EPS NY rev (3m)-19.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.43%
Revenue NY rev (1m)3.88%
Revenue NY rev (3m)-4.46%
Valuation
Industry RankSector Rank
PE 21.44
Fwd PE 16.38
P/S 3.21
P/FCF 70.32
P/OCF 13.57
P/B 2.58
P/tB 5.84
EV/EBITDA 13.39
EPS(TTM)1.68
EY4.66%
EPS(NY)2.2
Fwd EY6.1%
FCF(TTM)0.51
FCFY1.42%
OCF(TTM)2.65
OCFY7.37%
SpS11.24
BVpS13.96
TBVpS6.17
PEG (NY)N/A
PEG (5Y)1.36
Profitability
Industry RankSector Rank
ROA 3.13%
ROE 5.11%
ROCE 7.35%
ROIC 5.98%
ROICexc 6.49%
ROICexgc 11.74%
OM 12.38%
PM (TTM) 6.34%
GM 39.68%
FCFM 4.56%
ROA(3y)7.79%
ROA(5y)5.95%
ROE(3y)13.34%
ROE(5y)10.66%
ROIC(3y)11.24%
ROIC(5y)8.52%
ROICexc(3y)13.19%
ROICexc(5y)10.13%
ROICexgc(3y)27.93%
ROICexgc(5y)22.61%
ROCE(3y)13.84%
ROCE(5y)10.48%
ROICexcg growth 3Y-5.66%
ROICexcg growth 5Y1.68%
ROICexc growth 3Y6.77%
ROICexc growth 5Y-4.81%
OM growth 3Y8.56%
OM growth 5Y3.29%
PM growth 3Y-6.29%
PM growth 5Y-4.73%
GM growth 3Y1.76%
GM growth 5Y1.71%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 7.98
Debt/EBITDA 1.28
Cap/Depr 147.52%
Cap/Sales 19.06%
Interest Coverage 250
Cash Conversion 93.35%
Profit Quality 71.86%
Current Ratio 1.98
Quick Ratio 1.11
Altman-Z 3.69
F-Score5
WACC9.86%
ROIC/WACC0.61
Cap/Depr(3y)151.77%
Cap/Depr(5y)128.29%
Cap/Sales(3y)17.6%
Cap/Sales(5y)15.83%
Profit Quality(3y)37.85%
Profit Quality(5y)92.91%
High Growth Momentum
Growth
EPS 1Y (TTM)-33.86%
EPS 3Y15.94%
EPS 5Y15.75%
EPS Q2Q%-35.85%
EPS Next Y-15.46%
EPS Next 2Y8.45%
EPS Next 3Y12.85%
EPS Next 5Y12%
Revenue 1Y (TTM)-8.61%
Revenue growth 3Y10.58%
Revenue growth 5Y13.25%
Sales Q2Q%-7.51%
Revenue Next Year0.85%
Revenue Next 2Y6.15%
Revenue Next 3Y7.49%
Revenue Next 5Y6.5%
EBIT growth 1Y-51.42%
EBIT growth 3Y20.04%
EBIT growth 5Y16.98%
EBIT Next Year56.82%
EBIT Next 3Y32.94%
EBIT Next 5Y25.22%
FCF growth 1Y-48.85%
FCF growth 3Y-66.12%
FCF growth 5Y-16.47%
OCF growth 1Y-9.15%
OCF growth 3Y-3.2%
OCF growth 5Y11.67%